BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37609875)

  • 1. Extracorporeal albumin dialysis in critically ill patients with liver failure: Comparison of four different devices-A retrospective analysis.
    Sommerfeld O; Neumann C; Becker J; von Loeffelholz C; Roth J; Kortgen A; Bauer M; Sponholz C
    Int J Artif Organs; 2023 Sep; 46(8-9):481-491. PubMed ID: 37609875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure-A retrospective analysis.
    Falkensteiner C; Kortgen A; Leonhardt J; Bauer M; Sponholz C
    Ther Apher Dial; 2021 Apr; 25(2):225-236. PubMed ID: 32515160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.
    Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F
    Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
    Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
    Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
    Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
    Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure.
    Fuhrmann V; Weber T; Roedl K; Motaabbed J; Tariparast A; Jarczak D; de Garibay APR; Kluwe J; Boenisch O; Herkner H; Kellum JA; Kluge S
    Ann Intensive Care; 2020 Jul; 10(1):96. PubMed ID: 32676849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    Kaps L; Ahlbrand CJ; Gadban R; Nagel M; Labenz C; Klimpke P; Holtz S; Boedecker S; Michel M; Kremer WM; Hilscher M; Galle PR; Kraus D; Schattenberg JM; Weinmann-Menke J
    PLoS One; 2021; 16(4):e0249342. PubMed ID: 33793644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular adsorbent recirculating system (MARS).
    Tan HK
    Ann Acad Med Singap; 2004 May; 33(3):329-35. PubMed ID: 15175774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis.
    Huber W; Henschel B; Schmid R; Al-Chalabi A
    BMC Gastroenterol; 2017 Feb; 17(1):32. PubMed ID: 28209134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearing of toxic substances: are there differences between the available liver support devices?
    Krisper P; Stadlbauer V; Stauber RE
    Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters].
    Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
    Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal renal and liver support in pediatric acute liver failure.
    Zoica BS; Deep A
    Pediatr Nephrol; 2021 May; 36(5):1119-1128. PubMed ID: 32500250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure.
    Ringe H; Varnholt V; Zimmering M; Luck W; Gratopp A; König K; Reich S; Sauer IM; Gaedicke G; Querfeld U
    Pediatr Crit Care Med; 2011 May; 12(3):257-64. PubMed ID: 20921923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of Single-Pass Albumin Dialysis (SPAD), Prometheus, and Molecular Adsorbent Recycling System (MARS) liver haemodialysis vs. Standard Medical Therapy (SMT): meta-analysis and systematic review.
    Gadour E; Kaballo MA; Shrwani K; Hassan Z; Kotb A; Aljuraysan A; Miuţescu B; Sherwani N; Mahallawi W
    Prz Gastroenterol; 2024; 19(2):101-111. PubMed ID: 38939063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study.
    Dominik A; Stange J; Pfensig C; Borufka L; Weiss-Reining H; Eggert M
    Ther Apher Dial; 2014 Aug; 18(4):347-52. PubMed ID: 24215331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial liver support systems.
    Tandon R; Froghi S
    J Gastroenterol Hepatol; 2021 May; 36(5):1164-1179. PubMed ID: 32918840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.